- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04536597
Quince Seed Jelly and Breast Milk on Nipple Fissures (QSJ)
The Effects of Quince Seed Jelly and Breast Milk on Nipple Fissures During Early Postpartum
Background: In various experimental or clinical studies, it has been reported that the jelly made from the quince seed is effective in healing wounds (attributed to the antioxidants, which increased fibroblast activity and collagen production, facilitated the formation of granulation tissue and increased blood circulation) and has no side effects or contraindications.
Purpose: To evaluates the effects of quince seed jelly and breast milk on nipple fissures.
Methods: Randomised controlled experimental study.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- primiparity,
- those having no nipple problems and allergy history
- volunteered to participate in the study
Exclusion Criteria:
- nipple problems and allergy history
- multiparity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Quince seed jelly group
|
Quince seed jelly, prepared by the researcher, was given to the mothers belonging to this group.
Briefly, 3 g (2-3 pieces) of quince seeds are placed in 100 mL water and heated to boiling for 10 min.
The prepared quince kernel was used for 3 days, immediately after cooling.14,15
On the 1st day postpartum, the researcher provided the mothers with practical training at the hospital, regarding the application of quince seed jelly to the nipple and areola and leaving it to dry.
This training was repeated on the 3rd, 7th and 10th days, to ensure that the mothers followed it precisely.
The training process was completed in 5-10 min, including questions and answers.
Every 3-4 days (days 1, 3, 7 and 10), quince seed jelly prepared by the researcher was given to the mothers to continue applying, according to the procedure.
The mothers were asked to apply it after every breastfeeding.
|
EXPERIMENTAL: Breast milk group
|
Mothers in this group received practical training, conducted by the researcher on the 1st day postpartum at the hospital, on applying a few drops of their breast milk to the nipples and areola after each breastfeeding and leaving it to dry.
This training lasted 5-10 min.
Breast milk application of mothers in this group was recorded on the 1st, 3rd, 7th and 10th days, by the researcher.
|
OTHER: Control group
Any kind of application that the mothers in the control group did for the nipple fissures were recorded on the 1st, 3rd, 7th and 10th days postpartum, by the researcher
|
Any kind of application that the mothers in the control group did for the nipple fissures were recorded on the 1st, 3rd, 7th and 10th days postpartum, by the researcher
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nipple pains and fissures
Time Frame: between the 1st and 10th days of the postpartum period
|
the Breast Care Monitoring Form
|
between the 1st and 10th days of the postpartum period
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- TRSIVAS01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postpartum
-
Women's College HospitalCanadian Institutes of Health Research (CIHR); Michael Garron HospitalCompletedPostpartum Depression | Postpartum Anxiety | Postpartum Blues | Postpartum Mood DisorderCanada
-
University Hospital, Clermont-FerrandUnknownPostpartum Depression | Postpartum Hemorrhage | Postpartum Women | Postpartum Stress | Postpartum AnxietyFrance
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPostpartumUnited States, Guatemala
-
Assistance Publique Hopitaux De MarseilleUnknown
-
The Jones InstituteUnknownPostpartum Depressive Mood | Postpartum Sexual FunctionUnited States
-
University of PittsburghAmerican Psychological Foundation; The Pittsburgh FoundationRecruitingPostpartum Depression | Pregnancy Related | Psychological Distress | Postpartum Sadness | Postpartum Anxiety | Postpartum BluesUnited States
-
Cairo UniversityRecruiting
-
London School of Hygiene and Tropical MedicineDepartment for International Development, United Kingdom; Economic and Social... and other collaboratorsCompleted
-
University of North Carolina, Chapel HillSociety of Family PlanningCompletedPostpartum ContraceptionUnited States
Clinical Trials on Quince seed jelly group
-
Gonabad University of Medical SciencesMashhad University of Medical SciencesCompleted
-
Pusan National University Yangsan HospitalCompletedChronic ConstipationKorea, Republic of
-
Centre Hospitalier Universitaire de NiceCompleted
-
University of the PhilippinesCommittee on Research Implementation and DevelopmentCompletedSuperficial Partial Thickness BurnsPhilippines
-
Beni-Suef UniversityUniversity of Arizona; Maternity and Children Hospital, MakkahCompletedCovid19 | ImmunodeficiencySaudi Arabia